Chronic cyclosporine administration induces renal P-glycoprotein in rats

Eur J Pharmacol. 2001 Apr 20;418(1-2):127-32. doi: 10.1016/s0014-2999(01)00927-x.

Abstract

The effect of cyclosporine doses on renal P-glycoprotein expression was examined. Rats were given cyclosporine orally at 2, 10, 30 mg/kg/day or subcutaneously at 1, 5, 15 mg/kg/day for 28 days with or without 14 days of additional vehicle dosing. Following cyclosporine dosing, renal function and P-glycoprotein expression were measured. Renal function was reduced in rats receiving oral cyclosporine and the highest subcutaneous dose, 15 mg/kg/day. Western blot analysis showed that cyclosporine administered orally at 10 and 30 mg/kg/day and subcutaneously at 15 mg/kg/day induced significantly renal P-glycoprotein expression. After discontinuation of cyclosporine, renal P-glycoprotein returned to pre-dosing levels in oral groups, whereas the return was incomplete in subcutaneous groups. These results indicate that cyclosporine induces renal P-glycoprotein overexpression a dose-dependent manner.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Administration, Oral
  • Animals
  • Cyclosporine / administration & dosage
  • Cyclosporine / pharmacology*
  • Cyclosporine / toxicity*
  • Dose-Response Relationship, Drug
  • Immunoblotting
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / pharmacology*
  • Immunosuppressive Agents / toxicity
  • Injections, Subcutaneous
  • Kidney / cytology
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / physiology
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Weight Gain / drug effects

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Immunosuppressive Agents
  • Cyclosporine